Publications

Detailed Information

C1q Tumor Necrosis Factor alpha-related Protein Isoform 5 Is Increased in Mitochondrial DNA-depleted Myocytes and Activates AMP-activated Protein Kinase

DC Field Value Language
dc.contributor.authorPark, Seung-Yoon-
dc.contributor.authorChoi, Jung Hyun-
dc.contributor.authorRyu, Hyun Su-
dc.contributor.authorKim Pak, Youngmi-
dc.contributor.authorLee, Hong Kyu-
dc.contributor.authorLee, Wan-
dc.contributor.authorPark, Kyong Soo-
dc.date.accessioned2012-05-24T06:56:29Z-
dc.date.available2012-05-24T06:56:29Z-
dc.date.issued2009-10-09-
dc.identifier.citationJOURNAL OF BIOLOGICAL CHEMISTRY; Vol.284 41; 27780-27789ko_KR
dc.identifier.issn0021-9258-
dc.identifier.urihttps://hdl.handle.net/10371/76431-
dc.description.abstractDepletion of mtDNA in myocytes causes insulin resistance and alters nuclear gene expression that may be involved in rescuing processes against cellular stress. Here we show that the expression of C1q tumor necrosis factor a-related protein isoform 5 (C1QTNF5) is drastically increased following depletion of mtDNA in myocytes. C1QTNF5 is homologous to adiponectin in respect to domain structure, and its expression and secretion from myocytes correlated negatively with the cellular mtDNA content. Similar to adiponectin, C1QTNF5 induced the phosphorylation of AMP-activated protein kinase (AMPK), leading to increased cell surface recruitment of GLUT4 and increased glucose uptake. Treatment of cells with purified recombinant C1QTNF5 increased the phosphorylation of acetyl-CoA carboxylase and stimulated fatty acid oxidation. C1QTNF5-mediated phosphorylation of AMPK or acetyl-CoA carboxylase was unaffected by depletion of adiponectin receptors such as AdipoR1 or AdipoR2, which indicated that adiponectin receptors do not participate in C1QTNF5-induced activation of AMPK. Serum C1QTNF5 levels were significantly higher in obese/diabetic animals (OLETF rats, ob/ob mice, and db/db mice). These results highlight C1QTNF5 as a putative biomarker for mitochondrial dysfunction and a potent activator of AMPK.ko_KR
dc.language.isoenko_KR
dc.publisherAMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INCko_KR
dc.titleC1q Tumor Necrosis Factor alpha-related Protein Isoform 5 Is Increased in Mitochondrial DNA-depleted Myocytes and Activates AMP-activated Protein Kinaseko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor박승윤-
dc.contributor.AlternativeAuthor최정현-
dc.contributor.AlternativeAuthor류현수-
dc.contributor.AlternativeAuthor박경수-
dc.contributor.AlternativeAuthor이홍규-
dc.contributor.AlternativeAuthor이완-
dc.contributor.AlternativeAuthor김영미-
dc.identifier.doi10.1074/jbc.M109.005611-
dc.citation.journaltitleJOURNAL OF BIOLOGICAL CHEMISTRY-
dc.description.citedreferenceWong GW, 2008, BIOCHEM J, V416, P161, DOI 10.1042/BJ20081240-
dc.description.citedreferencePalanivel R, 2007, CARDIOVASC RES, V75, P148, DOI 10.1016/j.cardiores.2007.04.011-
dc.description.citedreferenceRyan MT, 2007, ANNU REV BIOCHEM, V76, P701, DOI 10.1146/annurev.biochem.76.052305.091720-
dc.description.citedreferenceYoon MJ, 2006, DIABETES, V55, P2562, DOI 10.2337/db05-1322-
dc.description.citedreferenceHardie DG, 2006, J PHYSIOL-LONDON, V574, P7, DOI 10.1113/jphysiol.2006.108944-
dc.description.citedreferenceAkiyama H, 2006, FEBS J, V273, P2257, DOI 10.1111/j.1742-4658.2006.05240.x-
dc.description.citedreferenceMaeda T, 2006, J CELL PHYSIOL, V206, P537, DOI 10.1002/jcp.20493-
dc.description.citedreferenceLasser G, 2006, BLOOD, V107, P423, DOI 10.1182/blood-2005-04-1425-
dc.description.citedreferenceFang X, 2005, J MOL ENDOCRINOL, V35, P465, DOI 10.1677/jme.1.01877-
dc.description.citedreferenceBiswas G, 2005, GENE, V354, P132, DOI 10.1016/j.gene.2005.03.028-
dc.description.citedreferenceTang YT, 2005, GENOMICS, V86, P100, DOI 10.1016/j.ygeno.2005.03.001-
dc.description.citedreferencePark SY, 2005, J BIOL CHEM, V280, P9855, DOI 10.1074/jbc.M409399200-
dc.description.citedreferenceWallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751-
dc.description.citedreferenceKottom TJ, 2004, INFECT IMMUN, V72, P4628, DOI 10.1128/IAI.72.8.4628-4636.2004-
dc.description.citedreferenceWong GW, 2004, P NATL ACAD SCI USA, V101, P10302, DOI 10.1073/pnas.0403760101-
dc.description.citedreferenceCarling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005-
dc.description.citedreferenceHayward C, 2003, HUM MOL GENET, V12, P2657, DOI 10.1093/hmg/ddg289-
dc.description.citedreferenceYamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705-
dc.description.citedreferenceSomwar R, 2002, J BIOL CHEM, V277, P50386, DOI 10.1074/jbc.M205277200-
dc.description.citedreferenceTomas E, 2002, P NATL ACAD SCI USA, V99, P16309, DOI 10.1073/pnas.222657499-
dc.description.citedreferenceYamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788-
dc.description.citedreferenceKim JY, 2002, AM J PHYSIOL-ENDOC M, V282, pE1014, DOI 10.1152/ajpendo.00233.2001-
dc.description.citedreferenceMu J, 2001, MOL CELL, V7, P1085-
dc.description.citedreferenceShulman GI, 2000, J CLIN INVEST, V106, P171-
dc.description.citedreferenceKurth-Kraczek EJ, 1999, DIABETES, V48, P1667-
dc.description.citedreferenceHayashi T, 1998, DIABETES, V47, P1369-
dc.description.citedreferenceMerrill GF, 1997, AM J PHYSIOL-ENDOC M, V273, pE1107-
dc.description.citedreferenceVavvas D, 1997, J BIOL CHEM, V272, P13255-
dc.description.citedreferenceKAWANO K, 1994, DIABETES RES CLIN PR, V24, pS317-
dc.description.citedreferenceKANAI F, 1993, J BIOL CHEM, V268, P14523-
dc.description.tc12-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share